144 related articles for article (PubMed ID: 12536196)
1. Ribozyme-mediated cleavage of the human survivin mRNA and inhibition of antiapoptotic function of survivin in MCF-7 cells.
Choi KS; Lee TH; Jung MH
Cancer Gene Ther; 2003 Feb; 10(2):87-95. PubMed ID: 12536196
[TBL] [Abstract][Full Text] [Related]
2. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells.
Pennati M; Binda M; Colella G; Zoppe' M; Folini M; Vignati S; Valentini A; Citti L; De Cesare M; Pratesi G; Giacca M; Daidone MG; Zaffaroni N
Oncogene; 2004 Jan; 23(2):386-94. PubMed ID: 14724567
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of survivin expression by small interfering RNA induces apoptosis in human breast carcinoma cell line MCF-7.
Li JX; Zhou KY; Liang T; Zhang YF
Ai Zheng; 2005 Mar; 24(3):268-72. PubMed ID: 15757525
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
7. DNAzyme-mediated cleavage of survivin mRNA and inhibition of the growth of PANC-1 cells.
Liang Z; Wei S; Guan J; Luo Y; Gao J; Zhu H; Wu S; Liu T
J Gastroenterol Hepatol; 2005 Oct; 20(10):1595-602. PubMed ID: 16174080
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
[TBL] [Abstract][Full Text] [Related]
9. Survivin gene RNA interference inhibits proliferation, induces apoptosis, and enhances radiosensitivity in HeLa cells.
Song H; Xin XY; Xiao F; Wang DT; Yue QH; Han X
Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):83-9. PubMed ID: 17098350
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells.
Kami K; Doi R; Koizumi M; Toyoda E; Mori T; Ito D; Kawaguchi Y; Fujimoto K; Wada M; Miyatake S; Imamura M
Surgery; 2005 Aug; 138(2):299-305. PubMed ID: 16153440
[TBL] [Abstract][Full Text] [Related]
11. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
[TBL] [Abstract][Full Text] [Related]
12. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy.
Olie RA; Simões-Wüst AP; Baumann B; Leech SH; Fabbro D; Stahel RA; Zangemeister-Wittke U
Cancer Res; 2000 Jun; 60(11):2805-9. PubMed ID: 10850418
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D
Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801
[TBL] [Abstract][Full Text] [Related]
14. Ribozyme-mediated down-regulation of survivin expression sensitizes human melanoma cells to topotecan in vitro and in vivo.
Pennati M; Binda M; De Cesare M; Pratesi G; Folini M; Citti L; Daidone MG; Zunino F; Zaffaroni N
Carcinogenesis; 2004 Jul; 25(7):1129-36. PubMed ID: 14764461
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
Hayashidani Y; Hiyama E; Murakami Y; Sueda T
Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
[TBL] [Abstract][Full Text] [Related]
16. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
Moriai R; Tsuji N; Moriai M; Kobayashi D; Watanabe N
Breast Cancer Res Treat; 2009 Sep; 117(2):261-71. PubMed ID: 18815881
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.
Zhang M; Mukherjee N; Bermudez RS; Latham DE; Delaney MA; Zietman AL; Shipley WU; Chakravarti A
Prostate; 2005 Aug; 64(3):293-302. PubMed ID: 15754318
[TBL] [Abstract][Full Text] [Related]
18. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death.
Yamaguchi Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Saitou Y; Sugimoto K; Nakano T
Oncol Rep; 2005 Nov; 14(5):1311-6. PubMed ID: 16211302
[TBL] [Abstract][Full Text] [Related]
19. Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis.
Wall NR; O'Connor DS; Plescia J; Pommier Y; Altieri DC
Cancer Res; 2003 Jan; 63(1):230-5. PubMed ID: 12517802
[TBL] [Abstract][Full Text] [Related]
20. Survivin mediates resistance to antiandrogen therapy in prostate cancer.
Zhang M; Latham DE; Delaney MA; Chakravarti A
Oncogene; 2005 Apr; 24(15):2474-82. PubMed ID: 15735703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]